anticancer agents (Cerylid)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameanticancer agents (Cerylid)
Drug Alias NameCBL-317CBL-318
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCerylid Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCerylid Biosciences
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A